Research Grant-Writing Education Mentorship Available.
- Published in:
- ONS News, 2006, v. 21, n. 2, p. 8
- Publication type:
- Article
Works matching DE "SANOFI-Aventis SA"
Results: 150
1
2
Are You an APN Who Needs Help Submitting a Research Proposal?
- Published in:
- ONS News, 2005, v. 20, n. 13, p. 14
- Publication type:
- Article
3
Sanofi and Boehringer Ingelheim sign agreement.
- Published in:
- Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2016, v. 57, n. 10, p. 1100
- Publication type:
- Article
4
Antimalarial Drugs--Here and On the Horizon.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 20, p. 2185, doi. 10.1001/jama.297.20.2185
- By:
- Publication type:
- Article
5
Predation in off-patent drug markets.
- Published in:
- Applied Economics, 2012, v. 44, n. 17, p. 2171, doi. 10.1080/00036846.2011.562169
- By:
- Publication type:
- Article
6
What is the Urologist to do in a BCG Shortage?
- Published in:
- AUANews, 2014, v. 19, n. 11, p. 1
- Publication type:
- Article
7
Dengue Vaccine: The Need, the Challenges, and Progress.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
8
New molecular entities.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 223
- Publication type:
- Article
9
Drug Watch.
- Published in:
- Formulary, 2007, v. 42, n. 11, p. 656
- Publication type:
- Article
10
Drug Watch.
- Published in:
- Formulary, 2006, v. 41, n. 6, p. 296
- Publication type:
- Article
11
Ambien CR.
- Published in:
- Formulary, 2005, v. 40, n. 10, p. 322
- Publication type:
- Article
12
Pipeline preview.
- Published in:
- Formulary, 2005, v. 40, n. 10, p. 321
- Publication type:
- Article
13
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 571
- Publication type:
- Article
14
Medical writing in India at a crossroads.
- Published in:
- Medical Writing, 2013, v. 22, n. 2, p. 94, doi. 10.1179/2047480613Z.000000000106
- By:
- Publication type:
- Article
15
PsychRx.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 9, p. 10
- Publication type:
- Article
16
Medicines Australia Code of Conduct: breaches.
- Published in:
- Australian Prescriber, 2012, v. 35, n. 6, p. 207, doi. 10.18773/austprescr.2012.088
- Publication type:
- Article
17
Seven days: 28 January?3 February 2011.
- Published in:
- Nature, 2011, v. 470, n. 7332, p. 10, doi. 10.1038/470010a
- Publication type:
- Article
18
News briefing: 18 March 2010.
- Published in:
- Nature, 2010, v. 464, n. 7287, p. 330, doi. 10.1038/464330a
- Publication type:
- Article
19
Sanofi and BIDE sign MoU to promote better diabetes management.
- Published in:
- Pulse International, 2014, v. 15, n. 5, p. 15
- Publication type:
- Article
20
Sanofi and DAP sign MoU to improve quality care for diabetic patients.
- Published in:
- Pulse International, 2012, v. 13, n. 7, p. 13
- Publication type:
- Article
21
New diabetes drug lixisenatide shows promise in Phase III clinical trials.
- Published in:
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 717
- Publication type:
- Article
22
France's Sanofi Partners US Army to Speed up Zika Vaccine.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 7, p. ii, doi. 10.1093/cid/ciw503
- Publication type:
- Article
23
Sanofi Wins US OK for Short Needle Flu Vaccine.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 107, doi. 10.1093/cid/cir397
- Publication type:
- Article
24
News.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 10, p. i, doi. 10.1093/cid/cir252
- Publication type:
- Article
25
News.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 10, p. i, doi. 10.1086/657565
- By:
- Publication type:
- Article
26
US Clears High-Dose Sanofi Seasonal Flu Vaccine for Elderly.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 4, p. i
- By:
- Publication type:
- Article
27
Sanofi to Donate 100 Million Flu Shots to WHO.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 4, p. ii
- Publication type:
- Article
28
Announcement.
- Published in:
- Diabetic Medicine, 2007, v. 24, n. 8, p. i, doi. 10.1111/j.1464-5491.2007.02246.x
- Publication type:
- Article
29
Embracing digital health in the Pharmaceutical Industry.
- Published in:
- International Journal of Healthcare Management, 2016, v. 9, n. 3, p. 145, doi. 10.1080/20479700.2016.1197513
- By:
- Publication type:
- Article
30
STUDY REGARDING THE EVOLUTION OF THE FINANCIAL BALANCE IN THE PHARMACEUTICAL INDUSTRY.
- Published in:
- Revista Economică, 2015, v. 67, n. 1, p. 68
- By:
- Publication type:
- Article
31
Global Supply of Yellow Fever Vaccine Depleted—W.H.O.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 9, p. iii
- Publication type:
- Article
32
Sanofi Targets Elderly with New Type of Flu Shot.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 8, p. iv
- Publication type:
- Article
33
FDA Approves Sanofi Bird Flu Vaccine.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 12, p. iv
- Publication type:
- Article
34
Sanofi Launches Cut-Price Malaria Pill for Africa.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- By:
- Publication type:
- Article
35
Glaxo Bird Flu Shot Fights Different H5N1 Strains.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- By:
- Publication type:
- Article
36
Experts Support First U.S. Bird Flu Vaccine.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- By:
- Publication type:
- Article
37
FDA Panel Urges Limits on Ketek Antibiotic.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 4, p. iii
- By:
- Publication type:
- Article
38
EU Asks for Stronger Warnings on Sanofi's Ketek.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 8, p. 2
- Publication type:
- Article
39
US Clears Sanofi-Aventis Whooping Cough Vaccine.
- Published in:
- Clinical Infectious Diseases, 2005, v. 41, n. 3, p. 1
- Publication type:
- Article
40
DATA SUPPORT NEW MENINGITIS VACCINE-- U.S. PANEL.
- Published in:
- Clinical Infectious Diseases, 2004, v. 39, n. 9, p. 1
- Publication type:
- Article
41
Sanofi-Aventis' hostile bid for Genzyme.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 833, p. 11
- Publication type:
- Article
42
Genzyme rejects Sanofi, sells genetic testing.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 832, p. 8
- Publication type:
- Article
43
Sanofi-Aventis helps Merck's merger, buys second half of Merial.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 819, p. 5
- Publication type:
- Article
44
Sanofi-Aventis works with Thales Nano on continuous processing.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 805, p. 5
- Publication type:
- Article
45
Straight talk with...Gary Nabel.
- Published in:
- Nature Medicine, 2013, v. 19, n. 3, p. 256, doi. 10.1038/nm0313-256
- Publication type:
- Article
46
Restructurally sound.
- Published in:
- Nature Medicine, 2011, v. 17, n. 5, p. 531, doi. 10.1038/nm0511-531
- By:
- Publication type:
- Article
47
Genzyme, though unique, could be a bellwether for US biotech.
- Published in:
- Nature Medicine, 2011, v. 17, n. 2, p. 145, doi. 10.1038/nm0211-145
- By:
- Publication type:
- Article
48
Free to fight disease.
- Published in:
- Nature Medicine, 2008, v. 14, n. 6, p. 594, doi. 10.1038/nm0608-594
- By:
- Publication type:
- Article
49
Pulpitis as clinical presentation of photoallergic contact dermatitis due to chlorpromazine.
- Published in:
- Allergy, 2011, v. 66, n. 11, p. 1503, doi. 10.1111/j.1398-9995.2011.02688.x
- By:
- Publication type:
- Article
50
Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 6, p. 647, doi. 10.1002/cpt.504
- By:
- Publication type:
- Article